Literature DB >> 9439677

In vitro enhancement of antitumor activity of a water-soluble duocarmycin derivative, KW-2189, by caffeine-mediated DNA-repair inhibition in human lung cancer cells.

H Ogasawara1, K Nishio, T Ishida, H Arioka, K Fukuoka, N Saijo.   

Abstract

Duocarmycins, including KW-2189, bind in the minor groove of double-stranded DNA at A-T-rich sequences, followed by covalent bonding with N-3 of adenine in preferred sequences. We examined the effect of DNA-repair modulators, such as caffeine and aphidicolin, on the cytotoxicity of duocarmycins towards human lung cancer cells, as determined by dye formation assay. Caffeine (0.5 or 1 mM), but not aphidicolin, enhanced the growth-inhibitory activity of KW-2189, DU-86, and duocarmycin SA. Caffeine inhibited repair of DNA strand breaks induced by KW-2189, as assayed by the alkaline elution technique. This suggests that duocarmycin-induced DNA strand breaks, which are potentially lethal to cells, are repaired through a caffeine-sensitive pathway.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9439677      PMCID: PMC5921316          DOI: 10.1111/j.1349-7006.1997.tb00326.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  14 in total

1.  Recognition and repair of the CC-1065-(N3-adenine)-DNA adduct by the UVRABC nucleases.

Authors:  M S Tang; C S Lee; R Doisy; L Ross; D R Needham-VanDevanter; L H Hurley
Journal:  Biochemistry       Date:  1988-02-09       Impact factor: 3.162

2.  Poly(adenosinediphosphoribose) polymerase inhibitors stimulate unscheduled deoxyribonucleic acid synthesis in normal human lymphocytes.

Authors:  J L Sims; G W Sikorski; D M Catino; S J Berger; N A Berger
Journal:  Biochemistry       Date:  1982-04-13       Impact factor: 3.162

3.  Depletion of nicotinamide adenine dinucleotide in normal and xeroderma pigmentosum fibroblast cells by the antitumor drug CC-1065.

Authors:  M K Jacobson; D Twehous; L H Hurley
Journal:  Biochemistry       Date:  1986-10-07       Impact factor: 3.162

4.  Characteristics of antitumor activity of KW-2189, a novel water-soluble derivative of duocarmycin, against murine and human tumors.

Authors:  E Kobayashi; A Okamoto; M Asada; M Okabe; S Nagamura; A Asai; H Saito; K Gomi; T Hirata
Journal:  Cancer Res       Date:  1994-05-01       Impact factor: 12.701

5.  Resistance of human cervical carcinoma cells to tumor necrosis factor correlates with their increased sensitivity to cisplatin: evidence of a role for DNA repair and epidermal growth factor receptor.

Authors:  K Nishikawa; M G Rosenblum; R A Newman; T K Pandita; W N Hittelman; N J Donato
Journal:  Cancer Res       Date:  1992-09-01       Impact factor: 12.701

6.  An intrastrand d(GpG) platinum crosslink in duplex M13 DNA is refractory to repair by human cell extracts.

Authors:  D E Szymkowski; K Yarema; J M Essigmann; S J Lippard; R D Wood
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

7.  Formation and repair of antitumor antibiotic CC-1065-induced DNA adducts in the adenine phosphoribosyltransferase and amplified dihydrofolate reductase genes of Chinese hamster ovary cells.

Authors:  M S Tang; M Qian; A Pao
Journal:  Biochemistry       Date:  1994-03-08       Impact factor: 3.162

8.  Caffeine enhancement of the effect of anticancer agents on human sarcoma cells.

Authors:  K Tomita; H Tsuchiya
Journal:  Jpn J Cancer Res       Date:  1989-01

9.  Anticellular and antitumor activity of duocarmycins, novel antitumor antibiotics.

Authors:  K Gomi; E Kobayashi; K Miyoshi; T Ashizawa; A Okamoto; T Ogawa; S Katsumata; A Mihara; M Okabe; T Hirata
Journal:  Jpn J Cancer Res       Date:  1992-01

10.  A novel antitumor antibiotic, KW-2189 is activated by carboxyl esterase and induces DNA strand breaks in human small cell lung cancer cells.

Authors:  H Ogasawara; K Nishio; Y Takeda; T Ohmori; N Kubota; Y Funayama; T Ohira; Y Kuraishi; Y Isogai; N Saijo
Journal:  Jpn J Cancer Res       Date:  1994-04
View more
  1 in total

1.  Circulating metabolite profiles to predict overall survival in advanced non-small cell lung cancer patients receiving first-line chemotherapy.

Authors:  Jie Shen; Yuanqing Ye; David W Chang; Maosheng Huang; John V Heymach; Jack A Roth; Xifeng Wu; Hua Zhao
Journal:  Lung Cancer       Date:  2017-11-02       Impact factor: 5.705

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.